CRF Health Introduces eCOA Solution for Oncology Trials
Plymouth Meeting, PA – August 10, 2015: CRF Health, the leading global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, introduces a complete TrialMax® eCOA solution specifically for oncology clinical trials. Developed based on CRF Health's experience of delivering over 100 successful global oncology studies, the solution streamlines data collection by combining an eCOA capture system with intuitive site and patient management tools. Reporting concomitant medication data is also simplified, enabling sponsors to collect complete data while reducing patient and investigator burden.
The length, complexity and increased data demands of oncology trials places a considerable burden on patients, sites and study teams alike. The identification of concomitant medication also brings its own challenges. CRF Health has incorporated its new TrialMax ConMed™ solution into the platform, allowing patients to easily report concomitant medication taken during a trial in real-time and deliver this data to investigators. This not only helps sponsors in identifying which side effects are related to the study drug, but minimizes risk for resulting regulatory submissions.
"Busy site visits and sick patients taking multiple medications means that both investigators and patients may find it difficult to keep track of their condition in a way that meets the requirements of a trial's protocol. We have created this solution to support sponsors with the common problems they face in oncology trials and to collect data which shows the efficacy of the drug in near to real-time”, comments Rauha Tulkki-Wilke, VP Product and Service Management at CRF Health. “In doing so, we have been able to reduce burden on patients and site staff, resulting in improved retention and adherence, two of the biggest challenges in oncology studies.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
